Skip to main content

and
  1. Article

    Open Access

    Aptameric hirudins as selective and reversible EXosite-ACTive site (EXACT) inhibitors

    Potent and selective inhibition of the structurally homologous proteases of coagulation poses challenges for drug development. Hematophagous organisms frequently accomplish this by fashioning peptide inhibitor...

    Haixiang Yu, Shekhar Kumar, James W. Frederiksen in Nature Communications (2024)

  2. No Access

    Article

    Combination of aptamer and drug for reversible anticoagulation in cardiopulmonary bypass

    An aptamer is combined with a drug to prevent clot formation in a model of cardiopulmonary bypass.

    Ruwan Gunaratne, Shekhar Kumar, James W Frederiksen in Nature Biotechnology (2018)